Galli, Mattia
 Distribuzione geografica
Continente #
NA - Nord America 1.930
AS - Asia 1.468
EU - Europa 1.096
SA - Sud America 278
AF - Africa 39
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.824
Nazione #
US - Stati Uniti d'America 1.888
SG - Singapore 708
CN - Cina 268
SE - Svezia 260
BR - Brasile 223
IT - Italia 195
VN - Vietnam 184
FR - Francia 150
DE - Germania 139
IE - Irlanda 75
IN - India 52
JP - Giappone 51
ID - Indonesia 50
GB - Regno Unito 49
FI - Finlandia 47
PL - Polonia 46
HK - Hong Kong 40
RU - Federazione Russa 33
IQ - Iraq 22
CA - Canada 21
UA - Ucraina 21
NL - Olanda 19
AR - Argentina 18
BD - Bangladesh 16
MX - Messico 15
AT - Austria 12
CZ - Repubblica Ceca 11
ET - Etiopia 11
AU - Australia 9
CI - Costa d'Avorio 9
IR - Iran 9
CO - Colombia 8
KR - Corea 8
PK - Pakistan 8
TR - Turchia 8
VE - Venezuela 8
ZA - Sudafrica 7
BE - Belgio 6
LT - Lituania 6
AZ - Azerbaigian 5
EC - Ecuador 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CH - Svizzera 4
ES - Italia 4
IL - Israele 4
JO - Giordania 4
QA - Qatar 4
UY - Uruguay 4
CL - Cile 3
EG - Egitto 3
EU - Europa 3
MA - Marocco 3
NP - Nepal 3
PT - Portogallo 3
SA - Arabia Saudita 3
TW - Taiwan 3
UZ - Uzbekistan 3
AL - Albania 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
PH - Filippine 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SO - Somalia 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.824
Città #
Singapore 389
Chandler 319
Ashburn 175
San Jose 173
New York 89
Beijing 85
Dublin 74
Ho Chi Minh City 64
Los Angeles 52
Jakarta 47
Hanoi 44
Lauterbourg 42
Warsaw 42
Tokyo 41
The Dalles 40
Milan 37
San Mateo 37
Princeton 35
Boston 33
Rome 33
Hong Kong 32
Helsinki 31
Wilmington 31
Bremen 28
Dallas 28
Marseille 28
Frankfurt am Main 24
Moscow 23
Hefei 22
Munich 22
São Paulo 22
Fairfield 18
Redwood City 18
Cattolica 17
Baghdad 15
Woodbridge 15
Chicago 14
Augusta 13
Paris 13
Da Nang 11
Seattle 11
Atlanta 10
Dearborn 10
Haiphong 10
Houston 10
Pune 10
Turku 10
Abidjan 9
Jacksonville 9
London 9
North Bergen 9
Orem 9
Denver 8
Düsseldorf 8
Falkenstein 8
Rio de Janeiro 8
Santa Clara 8
Seoul 8
St Louis 8
Amsterdam 7
Brooklyn 7
Buffalo 7
Montreal 7
Nuremberg 7
Roubaix 7
Saint Louis 7
Stockholm 7
Vienna 7
Belo Horizonte 6
Brasília 6
Brussels 6
Groningen 6
Kent 6
Lappeenranta 6
Mumbai 6
Naples 6
Washington 6
Ann Arbor 5
Asunción 5
Baku 5
Brno 5
Curitiba 5
Dhaka 5
Guangzhou 5
Hyderabad 5
Leawood 5
Nanjing 5
Orangeburg 5
Phoenix 5
Poplar 5
San Francisco 5
Amman 4
Andover 4
Cambridge 4
Catania 4
Chennai 4
City of London 4
Doha 4
Elk Grove Village 4
Florence 4
Totale 2.671
Nome #
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 235
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 177
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 165
Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology 159
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials 157
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 152
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation 138
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 134
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 132
Comprehensive functional and anatomic assessment of myocardial bridging: Unlocking the Gordian Knot 127
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 127
Where Does Inflammation Fit? 123
Dual quantitative coronary angiography accurately quantifies intracoronary thrombotic burden in patients with acute coronary syndrome: Comparison with optical coherence tomography imaging 122
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis 122
Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of STEMI 120
A 3-Year Single Center Experience With Left Atrial Pressure Remote Monitoring: The Long and Winding Road 117
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs without left ventricular unloading by Impella: a systematic review and meta-analysis 116
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 115
Experience of Remote Cardiac Care during Covid-19 Pandemic: the V-LAP™ device in advanced heart failure 114
Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis 113
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials 113
Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysis 112
Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome? 111
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations 110
Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients 108
Neoatherosclerosis after drug-eluting stent implantation: A novel clinical and therapeutic challenge 101
Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 95
Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond 95
Efficacy and safety of dual pathway inhibition in patients with cardiovascular disease: a systematic review and Meta-analysis 94
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials 93
Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underling possible safety concerns 93
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis 92
Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy 90
How deep is your lesion? Extreme guideliner V3 intubation through RIMA graft to treat a distal left anterior descending artery stenosis 89
Response - Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underlying possible safety concerns 88
Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: Not a matter of faith 88
Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: A jump with a weak parachute? 87
Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives 81
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 78
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 74
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 70
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal 67
Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation–ACS/PCI Trials 47
Aspirin in primary prevention of cardiovascular disease in the elderly 45
Totale 4.886
Categoria #
all - tutte 21.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 15 31 7
2021/2022393 25 11 0 31 12 7 6 45 20 22 152 62
2022/2023921 102 108 65 143 47 124 56 80 136 10 29 21
2023/2024476 20 112 17 55 23 71 45 17 8 20 44 44
2024/2025816 19 14 68 44 65 46 28 39 113 98 165 117
2025/20261.963 349 34 96 233 404 84 417 102 147 97 0 0
Totale 4.886